HEADER IMMUNE SYSTEM 20-JAN-24 8VR9 TITLE STRUCTURE OF A SYNTHETIC ANTIBODY IN COMPLEX WITH A CLASS I MHC TITLE 2 PRESENTING A HAPTEN-PEPTIDE CONJUGATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 5 SYNONYM: HUMAN LEUKOCYTE ANTIGEN A,HLA-A; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: GTPASE KRAS, N-TERMINALLY PROCESSED; COMPND 13 CHAIN: C; COMPND 14 FRAGMENT: RESIDUES 8-16; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 OTHER_DETAILS: CYS12 CONJUGATED TO COVALENT INHIBITOR SOTORASIB; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: R023 FAB LIGHT CHAIN; COMPND 20 CHAIN: D; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 5; COMPND 23 MOLECULE: R023 FAB HEAVY CHAIN; COMPND 24 CHAIN: E; COMPND 25 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-A, HLAA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PHFT2; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_COMMON: HUMAN; SOURCE 23 ORGANISM_TAXID: 9606; SOURCE 24 MOL_ID: 4; SOURCE 25 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 29 MOL_ID: 5; SOURCE 30 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 31 ORGANISM_TAXID: 9606; SOURCE 32 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 33 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX, SYNTHETIC ANTIBODY, MHC CLASS I, COVALENTLY MODIFIED KEYWDS 2 PEPTIDE, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR L.MASO,I.BANG,S.KOIDE REVDAT 1 04-SEP-24 8VR9 0 JRNL AUTH L.MASO,E.RAJAK,I.BANG,A.KOIDE,T.HATTORI,B.G.NEEL,S.KOIDE JRNL TITL MOLECULAR BASIS FOR ANTIBODY RECOGNITION OF MULTIPLE JRNL TITL 2 DRUG-PEPTIDE/MHC COMPLEXES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 121 29121 2024 JRNL REFN ESSN 1091-6490 JRNL PMID 38781214 JRNL DOI 10.1073/PNAS.2319029121 REMARK 2 REMARK 2 RESOLUTION. 3.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, LEGINON, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.060 REMARK 3 NUMBER OF PARTICLES : 178888 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8VR9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JAN-24. REMARK 100 THE DEPOSITION ID IS D_1000280646. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : BINARY COMPLEX OF FAB R023 WITH REMARK 245 SOTORASIB-CONJUGATED KRAS G12C REMARK 245 PEPTIDE (8-16) PRESENTED BY REMARK 245 CLASS I MHC HAVING HLA-A*03:01; REMARK 245 FAB R023; CLASS I MHC, HAVING REMARK 245 HLA-A*03:01, WITH BETA-2- REMARK 245 MICROGLOBULIN; SOTORASIB- REMARK 245 CONJUGATED KRAS G12C PEPTIDE (8- REMARK 245 16) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 900.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2400.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5772.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 105000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -2 REMARK 465 ALA A -1 REMARK 465 SER A 0 REMARK 465 GLU A 275 REMARK 465 GLY B 19 REMARK 465 ASP D 1 REMARK 465 ILE D 2 REMARK 465 GLN D 3 REMARK 465 THR D 111 REMARK 465 VAL D 112 REMARK 465 ALA D 113 REMARK 465 ALA D 114 REMARK 465 PRO D 115 REMARK 465 SER D 116 REMARK 465 VAL D 117 REMARK 465 PHE D 118 REMARK 465 ILE D 119 REMARK 465 PHE D 120 REMARK 465 PRO D 121 REMARK 465 PRO D 122 REMARK 465 SER D 123 REMARK 465 ASP D 124 REMARK 465 SER D 125 REMARK 465 GLN D 126 REMARK 465 LEU D 127 REMARK 465 LYS D 128 REMARK 465 SER D 129 REMARK 465 GLY D 130 REMARK 465 THR D 131 REMARK 465 ALA D 132 REMARK 465 SER D 133 REMARK 465 VAL D 134 REMARK 465 VAL D 135 REMARK 465 CYS D 136 REMARK 465 LEU D 137 REMARK 465 LEU D 138 REMARK 465 ASN D 139 REMARK 465 ASN D 140 REMARK 465 PHE D 141 REMARK 465 TYR D 142 REMARK 465 PRO D 143 REMARK 465 ARG D 144 REMARK 465 GLU D 145 REMARK 465 ALA D 146 REMARK 465 LYS D 147 REMARK 465 VAL D 148 REMARK 465 GLN D 149 REMARK 465 TRP D 150 REMARK 465 LYS D 151 REMARK 465 VAL D 152 REMARK 465 ASP D 153 REMARK 465 ASN D 154 REMARK 465 ALA D 155 REMARK 465 LEU D 156 REMARK 465 GLN D 157 REMARK 465 SER D 158 REMARK 465 GLY D 159 REMARK 465 ASN D 160 REMARK 465 SER D 161 REMARK 465 GLN D 162 REMARK 465 GLU D 163 REMARK 465 SER D 164 REMARK 465 VAL D 165 REMARK 465 THR D 166 REMARK 465 GLU D 167 REMARK 465 GLN D 168 REMARK 465 ASP D 169 REMARK 465 SER D 170 REMARK 465 LYS D 171 REMARK 465 ASP D 172 REMARK 465 SER D 173 REMARK 465 THR D 174 REMARK 465 TYR D 175 REMARK 465 SER D 176 REMARK 465 LEU D 177 REMARK 465 SER D 178 REMARK 465 SER D 179 REMARK 465 THR D 180 REMARK 465 LEU D 181 REMARK 465 THR D 182 REMARK 465 LEU D 183 REMARK 465 SER D 184 REMARK 465 LYS D 185 REMARK 465 ALA D 186 REMARK 465 ASP D 187 REMARK 465 TYR D 188 REMARK 465 GLU D 189 REMARK 465 LYS D 190 REMARK 465 HIS D 191 REMARK 465 LYS D 192 REMARK 465 VAL D 193 REMARK 465 TYR D 194 REMARK 465 ALA D 195 REMARK 465 CYS D 196 REMARK 465 GLU D 197 REMARK 465 VAL D 198 REMARK 465 THR D 199 REMARK 465 HIS D 200 REMARK 465 GLN D 201 REMARK 465 GLY D 202 REMARK 465 LEU D 203 REMARK 465 SER D 204 REMARK 465 SER D 205 REMARK 465 PRO D 206 REMARK 465 VAL D 207 REMARK 465 THR D 208 REMARK 465 LYS D 209 REMARK 465 SER D 210 REMARK 465 PHE D 211 REMARK 465 ASN D 212 REMARK 465 ARG D 213 REMARK 465 GLY D 214 REMARK 465 GLU D 215 REMARK 465 CYS D 216 REMARK 465 GLU E -2 REMARK 465 ILE E -1 REMARK 465 SER E 0 REMARK 465 ASN E 118 REMARK 465 GLN E 119 REMARK 465 ILE E 120 REMARK 465 LYS E 121 REMARK 465 GLY E 122 REMARK 465 PRO E 123 REMARK 465 SER E 124 REMARK 465 VAL E 125 REMARK 465 PHE E 126 REMARK 465 PRO E 127 REMARK 465 LEU E 128 REMARK 465 ALA E 129 REMARK 465 PRO E 130 REMARK 465 SER E 131 REMARK 465 SER E 132 REMARK 465 LYS E 133 REMARK 465 SER E 134 REMARK 465 THR E 135 REMARK 465 SER E 136 REMARK 465 GLY E 137 REMARK 465 GLY E 138 REMARK 465 THR E 139 REMARK 465 ALA E 140 REMARK 465 ALA E 141 REMARK 465 LEU E 142 REMARK 465 GLY E 143 REMARK 465 CYS E 144 REMARK 465 LEU E 145 REMARK 465 VAL E 146 REMARK 465 LYS E 147 REMARK 465 ASP E 148 REMARK 465 TYR E 149 REMARK 465 PHE E 150 REMARK 465 PRO E 151 REMARK 465 GLU E 152 REMARK 465 PRO E 153 REMARK 465 VAL E 154 REMARK 465 THR E 155 REMARK 465 VAL E 156 REMARK 465 SER E 157 REMARK 465 TRP E 158 REMARK 465 ASN E 159 REMARK 465 SER E 160 REMARK 465 GLY E 161 REMARK 465 ALA E 162 REMARK 465 LEU E 163 REMARK 465 THR E 164 REMARK 465 SER E 165 REMARK 465 GLY E 166 REMARK 465 VAL E 167 REMARK 465 HIS E 168 REMARK 465 THR E 169 REMARK 465 PHE E 170 REMARK 465 PRO E 171 REMARK 465 ALA E 172 REMARK 465 VAL E 173 REMARK 465 LEU E 174 REMARK 465 GLN E 175 REMARK 465 SER E 176 REMARK 465 SER E 177 REMARK 465 GLY E 178 REMARK 465 LEU E 179 REMARK 465 TYR E 180 REMARK 465 SER E 181 REMARK 465 LEU E 182 REMARK 465 SER E 183 REMARK 465 SER E 184 REMARK 465 VAL E 185 REMARK 465 VAL E 186 REMARK 465 THR E 187 REMARK 465 VAL E 188 REMARK 465 PRO E 189 REMARK 465 SER E 190 REMARK 465 SER E 191 REMARK 465 SER E 192 REMARK 465 LEU E 193 REMARK 465 GLY E 194 REMARK 465 THR E 195 REMARK 465 GLN E 196 REMARK 465 THR E 197 REMARK 465 TYR E 198 REMARK 465 ILE E 199 REMARK 465 CYS E 200 REMARK 465 ASN E 201 REMARK 465 VAL E 202 REMARK 465 ASN E 203 REMARK 465 HIS E 204 REMARK 465 LYS E 205 REMARK 465 PRO E 206 REMARK 465 SER E 207 REMARK 465 ASN E 208 REMARK 465 THR E 209 REMARK 465 LYS E 210 REMARK 465 VAL E 211 REMARK 465 ASP E 212 REMARK 465 LYS E 213 REMARK 465 LYS E 214 REMARK 465 VAL E 215 REMARK 465 GLU E 216 REMARK 465 PRO E 217 REMARK 465 LYS E 218 REMARK 465 SER E 219 REMARK 465 CYS E 220 REMARK 465 ASP E 221 REMARK 465 LYS E 222 REMARK 465 THR E 223 REMARK 465 HIS E 224 REMARK 465 THR E 225 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER B 20 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -132.21 58.77 REMARK 500 ASP A 30 40.71 -99.22 REMARK 500 GLN A 224 -60.20 -93.13 REMARK 500 THR A 225 -7.10 67.53 REMARK 500 ASP A 227 57.52 38.82 REMARK 500 LYS A 243 136.85 -172.34 REMARK 500 THR A 271 57.42 -142.81 REMARK 500 ASN B 41 -169.55 -125.86 REMARK 500 ALA B 99 -168.83 -160.46 REMARK 500 ARG D 24 53.71 -96.00 REMARK 500 GLN D 27 14.35 -151.00 REMARK 500 ALA D 51 -11.41 74.02 REMARK 500 SER D 52 -14.97 -140.77 REMARK 500 THR D 69 50.50 -90.50 REMARK 500 PRO D 80 46.30 -73.90 REMARK 500 ALA D 84 -168.19 -160.87 REMARK 500 SER E 55 -6.57 74.65 REMARK 500 ASP E 62 -6.52 71.56 REMARK 500 SER E 75 45.14 -88.68 REMARK 500 LYS E 76 -4.56 -143.54 REMARK 500 ALA E 92 -175.34 -171.83 REMARK 500 TRP E 101 -6.61 71.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-43478 RELATED DB: EMDB REMARK 900 STRUCTURE OF A SYNTHETIC ANTIBODY IN COMPLEX WITH A CLASS I MHC REMARK 900 PRESENTING A HAPTEN-PEPTIDE CONJUGATE DBREF 8VR9 A 1 275 UNP P04439 HLAA_HUMAN 25 299 DBREF 8VR9 B 21 119 UNP P61769 B2MG_HUMAN 21 119 DBREF 8VR9 C 8 16 UNP P01116 RASK_HUMAN 8 16 DBREF 8VR9 D 1 216 PDB 8VR9 8VR9 1 216 DBREF 8VR9 E -2 225 PDB 8VR9 8VR9 -2 225 SEQADV 8VR9 MET A -2 UNP P04439 INITIATING METHIONINE SEQADV 8VR9 ALA A -1 UNP P04439 EXPRESSION TAG SEQADV 8VR9 SER A 0 UNP P04439 EXPRESSION TAG SEQADV 8VR9 GLY B 19 UNP P61769 EXPRESSION TAG SEQADV 8VR9 SER B 20 UNP P61769 EXPRESSION TAG SEQADV 8VR9 CYS C 12 UNP P01116 GLY 12 VARIANT SEQRES 1 A 278 MET ALA SER GLY SER HIS SER MET ARG TYR PHE PHE THR SEQRES 2 A 278 SER VAL SER ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE SEQRES 3 A 278 ALA VAL GLY TYR VAL ASP ASP THR GLN PHE VAL ARG PHE SEQRES 4 A 278 ASP SER ASP ALA ALA SER GLN ARG MET GLU PRO ARG ALA SEQRES 5 A 278 PRO TRP ILE GLU GLN GLU GLY PRO GLU TYR TRP ASP GLN SEQRES 6 A 278 GLU THR ARG ASN VAL LYS ALA GLN SER GLN THR ASP ARG SEQRES 7 A 278 VAL ASP LEU GLY THR LEU ARG GLY TYR TYR ASN GLN SER SEQRES 8 A 278 GLU ALA GLY SER HIS THR ILE GLN ILE MET TYR GLY CYS SEQRES 9 A 278 ASP VAL GLY SER ASP GLY ARG PHE LEU ARG GLY TYR ARG SEQRES 10 A 278 GLN ASP ALA TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN SEQRES 11 A 278 GLU ASP LEU ARG SER TRP THR ALA ALA ASP MET ALA ALA SEQRES 12 A 278 GLN ILE THR LYS ARG LYS TRP GLU ALA ALA HIS GLU ALA SEQRES 13 A 278 GLU GLN LEU ARG ALA TYR LEU ASP GLY THR CYS VAL GLU SEQRES 14 A 278 TRP LEU ARG ARG TYR LEU GLU ASN GLY LYS GLU THR LEU SEQRES 15 A 278 GLN ARG THR ASP PRO PRO LYS THR HIS MET THR HIS HIS SEQRES 16 A 278 PRO ILE SER ASP HIS GLU ALA THR LEU ARG CYS TRP ALA SEQRES 17 A 278 LEU GLY PHE TYR PRO ALA GLU ILE THR LEU THR TRP GLN SEQRES 18 A 278 ARG ASP GLY GLU ASP GLN THR GLN ASP THR GLU LEU VAL SEQRES 19 A 278 GLU THR ARG PRO ALA GLY ASP GLY THR PHE GLN LYS TRP SEQRES 20 A 278 ALA ALA VAL VAL VAL PRO SER GLY GLU GLU GLN ARG TYR SEQRES 21 A 278 THR CYS HIS VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU SEQRES 22 A 278 THR LEU ARG TRP GLU SEQRES 1 B 101 GLY SER ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER SEQRES 2 B 101 ARG HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN SEQRES 3 B 101 CYS TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL SEQRES 4 B 101 ASP LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU SEQRES 5 B 101 HIS SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR SEQRES 6 B 101 LEU LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP SEQRES 7 B 101 GLU TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN SEQRES 8 B 101 PRO LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 VAL VAL GLY ALA CYS GLY VAL GLY LYS SEQRES 1 D 216 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 D 216 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 D 216 GLN SER VAL SER SER ALA VAL ALA TRP TYR GLN GLN LYS SEQRES 4 D 216 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR SER ALA SER SEQRES 5 D 216 SER LEU TYR SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 D 216 ARG SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 D 216 GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN ALA SEQRES 8 D 216 SER TYR VAL ARG LYS THR ILE THR PHE GLY GLN GLY THR SEQRES 9 D 216 LYS VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL SEQRES 10 D 216 PHE ILE PHE PRO PRO SER ASP SER GLN LEU LYS SER GLY SEQRES 11 D 216 THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO SEQRES 12 D 216 ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU SEQRES 13 D 216 GLN SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SEQRES 14 D 216 SER LYS ASP SER THR TYR SER LEU SER SER THR LEU THR SEQRES 15 D 216 LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA SEQRES 16 D 216 CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR SEQRES 17 D 216 LYS SER PHE ASN ARG GLY GLU CYS SEQRES 1 E 228 GLU ILE SER GLU VAL GLN LEU VAL GLU SER GLY GLY GLY SEQRES 2 E 228 LEU VAL GLN PRO GLY GLY SER LEU ARG LEU SER CYS ALA SEQRES 3 E 228 ALA SER GLY PHE THR PHE SER ASP TYR SER ILE HIS TRP SEQRES 4 E 228 VAL ARG GLN ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA SEQRES 5 E 228 SER ILE SER SER SER SER GLY SER THR SER TYR ALA ASP SEQRES 6 E 228 SER VAL LYS GLY ARG PHE THR ILE SER ALA ASP THR SER SEQRES 7 E 228 LYS ASN THR ALA TYR LEU GLN MET ASN SER LEU ARG ALA SEQRES 8 E 228 GLU ASP THR ALA VAL TYR TYR CYS ALA ARG GLY GLY TRP SEQRES 9 E 228 ILE ALA ALA MET ASP TYR TRP GLY GLN GLY THR LEU VAL SEQRES 10 E 228 THR VAL PHE ASN GLN ILE LYS GLY PRO SER VAL PHE PRO SEQRES 11 E 228 LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA SEQRES 12 E 228 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 E 228 VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY SEQRES 14 E 228 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 E 228 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 E 228 LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS SEQRES 17 E 228 PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 18 E 228 SER CYS ASP LYS THR HIS THR HET MOV E 301 41 HETNAM MOV AMG 510 (BOUND FORM) HETSYN MOV 6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-4-[(2S)-2-METHYL- HETSYN 2 MOV 4-PROPANOYLPIPERAZIN-1-YL]-1-[4-METHYL-2-(PROPAN-2- HETSYN 3 MOV YL)PYRIDIN-3-YL]PYRIDO[2,3-D]PYRIMIDIN-2(1H)-ONE FORMUL 6 MOV C30 H32 F2 N6 O3 HELIX 1 AA1 GLY A 56 TYR A 85 1 30 HELIX 2 AA2 ALA A 140 ALA A 150 1 11 HELIX 3 AA3 HIS A 151 LEU A 156 1 6 HELIX 4 AA4 LEU A 156 THR A 163 1 8 HELIX 5 AA5 THR A 163 GLY A 175 1 13 HELIX 6 AA6 GLY A 175 GLN A 180 1 6 HELIX 7 AA7 VAL D 29 VAL D 33 5 5 HELIX 8 AA8 THR E 28 ASP E 31 5 4 HELIX 9 AA9 THR E 74 LYS E 76 5 3 HELIX 10 AB1 ARG E 87 THR E 91 5 5 SHEET 1 AA1 8 GLU A 46 PRO A 47 0 SHEET 2 AA1 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 AA1 8 ARG A 21 VAL A 28 -1 N ALA A 24 O PHE A 36 SHEET 4 AA1 8 HIS A 3 VAL A 12 -1 N PHE A 8 O VAL A 25 SHEET 5 AA1 8 THR A 94 VAL A 103 -1 O ILE A 97 N PHE A 9 SHEET 6 AA1 8 PHE A 109 TYR A 118 -1 O LEU A 110 N ASP A 102 SHEET 7 AA1 8 LYS A 121 LEU A 126 -1 O ILE A 124 N ASP A 116 SHEET 8 AA1 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AA2 4 LYS A 186 PRO A 193 0 SHEET 2 AA2 4 ALA A 199 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AA2 4 PHE A 241 VAL A 247 -1 O PHE A 241 N PHE A 208 SHEET 4 AA2 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 AA3 3 GLU A 222 ASP A 223 0 SHEET 2 AA3 3 ILE A 213 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 AA3 3 TYR A 257 HIS A 263 -1 O GLN A 262 N THR A 214 SHEET 1 AA4 4 LYS B 26 SER B 31 0 SHEET 2 AA4 4 ASN B 41 PHE B 50 -1 O TYR B 46 N GLN B 28 SHEET 3 AA4 4 PHE B 82 PHE B 90 -1 O THR B 88 N LEU B 43 SHEET 4 AA4 4 GLU B 70 HIS B 71 -1 N GLU B 70 O TYR B 87 SHEET 1 AA5 4 LYS B 26 SER B 31 0 SHEET 2 AA5 4 ASN B 41 PHE B 50 -1 O TYR B 46 N GLN B 28 SHEET 3 AA5 4 PHE B 82 PHE B 90 -1 O THR B 88 N LEU B 43 SHEET 4 AA5 4 SER B 75 PHE B 76 -1 N SER B 75 O TYR B 83 SHEET 1 AA6 3 GLU B 56 LYS B 61 0 SHEET 2 AA6 3 TYR B 98 ASN B 103 -1 O ARG B 101 N ASP B 58 SHEET 3 AA6 3 LYS B 111 ILE B 112 -1 O LYS B 111 N VAL B 102 SHEET 1 AA7 4 GLN D 6 SER D 7 0 SHEET 2 AA7 4 VAL D 19 CYS D 23 -1 O THR D 22 N SER D 7 SHEET 3 AA7 4 PHE D 71 ILE D 75 -1 O LEU D 73 N ILE D 21 SHEET 4 AA7 4 PHE D 62 ARG D 66 -1 N SER D 63 O THR D 74 SHEET 1 AA8 6 SER D 10 SER D 12 0 SHEET 2 AA8 6 THR D 104 GLU D 107 1 O GLU D 107 N LEU D 11 SHEET 3 AA8 6 THR D 85 SER D 92 -1 N TYR D 86 O THR D 104 SHEET 4 AA8 6 TRP D 35 GLN D 38 -1 N TYR D 36 O TYR D 87 SHEET 5 AA8 6 LYS D 45 TYR D 49 -1 O LEU D 47 N TRP D 35 SHEET 6 AA8 6 SER D 53 LEU D 54 -1 O SER D 53 N TYR D 49 SHEET 1 AA9 4 SER D 10 SER D 12 0 SHEET 2 AA9 4 THR D 104 GLU D 107 1 O GLU D 107 N LEU D 11 SHEET 3 AA9 4 THR D 85 SER D 92 -1 N TYR D 86 O THR D 104 SHEET 4 AA9 4 THR D 97 PHE D 100 -1 O THR D 97 N SER D 92 SHEET 1 AB1 4 GLN E 3 SER E 7 0 SHEET 2 AB1 4 LEU E 18 SER E 25 -1 O SER E 25 N GLN E 3 SHEET 3 AB1 4 THR E 78 MET E 83 -1 O MET E 83 N LEU E 18 SHEET 4 AB1 4 PHE E 68 ASP E 73 -1 N SER E 71 O TYR E 80 SHEET 1 AB2 6 LEU E 11 VAL E 12 0 SHEET 2 AB2 6 THR E 112 VAL E 116 1 O THR E 115 N VAL E 12 SHEET 3 AB2 6 ALA E 92 GLY E 99 -1 N TYR E 94 O THR E 112 SHEET 4 AB2 6 SER E 33 GLN E 39 -1 N VAL E 37 O TYR E 95 SHEET 5 AB2 6 LEU E 45 SER E 52 -1 O GLU E 46 N ARG E 38 SHEET 6 AB2 6 SER E 57 TYR E 60 -1 O SER E 59 N SER E 50 SHEET 1 AB3 4 LEU E 11 VAL E 12 0 SHEET 2 AB3 4 THR E 112 VAL E 116 1 O THR E 115 N VAL E 12 SHEET 3 AB3 4 ALA E 92 GLY E 99 -1 N TYR E 94 O THR E 112 SHEET 4 AB3 4 MET E 105 TRP E 108 -1 O TYR E 107 N ARG E 98 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.03 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.02 SSBOND 3 CYS B 45 CYS B 100 1555 1555 2.03 SSBOND 4 CYS D 23 CYS D 88 1555 1555 2.02 SSBOND 5 CYS E 22 CYS E 96 1555 1555 2.03 LINK SG CYS C 12 C25 MOV E 301 1555 1555 1.80 CISPEP 1 TYR A 209 PRO A 210 0 1.15 CISPEP 2 HIS B 51 PRO B 52 0 -1.67 CISPEP 3 SER D 7 PRO D 8 0 -3.84 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000